Oncology Research and Treatment-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2015-02-12 heyi8686

ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835

SCI查收：
JCR Abbrev. Title: ONKOLOGIE
Full Journal Title: ONKOLOGIE
ISO Abbrev. Title: Onkologie
ISSN: 0378-584X
Publisher: KARGER
Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
Language: GERMAN
Impact Factor: 0.835

424 0

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2014-09-09 匿名用户

看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎

410 0

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2014-07-26 匿名用户

感谢楼上的信息，我也试试

306 0

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2014-07-25 citron521

审稿速度:1.0 | 投稿命中率:75.0
经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。
邮件交换意见也很愉快，编辑友好。。。

362 0

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2011-09-03 childe85

审稿速度:6.0 | 投稿命中率:75.0
经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟.

412 0

[GetPortalCommentsPageByObjectIdResponse(id=509810, encodeId=4e3050981011, content=ONCOLOGY RESEARCH AND TREATMENT原名ONKOLOGIE，2013的IF是0.835 SCI查收： JCR Abbrev. Title: ONKOLOGIE Full Journal Title: ONKOLOGIE ISO Abbrev. Title: Onkologie ISSN: 0378-584X Publisher: KARGER Publisher Address: ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND Language: GERMAN Impact Factor: 0.835 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Thu Feb 12 14:02:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505909, encodeId=483a50590912, content=看到杂志有发CASE，就投了吗，投稿一周被拒，哎哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 09 10:12:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504336, encodeId=653950433653, content=感谢楼上的信息，我也试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 26 21:24:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504324, encodeId=8f3c504324e1, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：蛮好中的，德国人效率高。投了2周－3周就给回复接受了，但是很严谨还是帮着修改了很多语言的瑕疵。推荐这个杂志。。。临床基础转化型研究都接受好像。。。 邮件交换意见也很愉快，编辑友好。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Fri Jul 25 22:27:00 CST 2014, time=2014-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484249, encodeId=8717484249a6, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：个人感觉比较好投,唯一遗憾的就是审稿特别慢,着急出文章的就不要考虑了.本人是4月初投稿,8月底才返修.目前正在返修中.期间我发Email 询问过两次,均无回信.我都差点要放弃了.返修信才姗姗来迟., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6b845047, createdName=childe85, createdTime=Sat Sep 03 21:32:00 CST 2011, time=2011-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469540, encodeId=af0046954049, content=杂志名称：onkologie 专业领域：肿瘤的临床、基础学科 杂志国家：德国 投稿年份：2008.1 审稿周期:长 是否经历大小修：2次大修2次小修接受 从开始投稿到接受多长时间：14个月 期间是否要求润色语言：要求 是否收版面费：5页之内免费，超过5页每页390欧元 个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=567, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=minidoc, createdTime=Tue Dec 15 09:49:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2009-12-15 minidoc

杂志名称：onkologie

专业领域：肿瘤的临床、基础学科
杂志国家：德国
投稿年份：2008.1
审稿周期:长
是否经历大小修：2次大修2次小修接受
从开始投稿到接受多长时间：14个月
期间是否要求润色语言：要求
是否收版面费：5页之内免费，超过5页每页390欧元
个人评述（感受或经验）：我单位在上面已经发了2篇，谁知道我这篇会出现漫长的审稿和修回。但个人认为他们对文章的质量要求不高。

567 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务